Treatment of Supine Hypertension in Autonomic Failure
Public ClinicalTrials.gov record NCT00223717. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Pathophysiology and Treatment of Supine Hypertension in Patients With Autonomic Failure
Study identification
- NCT ID
- NCT00223717
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Vanderbilt University
- Other
- Enrollment
- 152 participants
Conditions and interventions
Conditions
Interventions
- Bosentan Drug
- Clonidine Drug
- Desmopressin (DDAVP) Drug
- Diltiazem Drug
- Dipyridamole/ Aspirin (Aggrenox) Drug
- Eplerenone Drug
- Head-up tilt. Other
- Hydralazine Drug
- Hydrochlorothiazide Drug
- L-arginine Dietary Supplement
- Local heat stress Other
- Nifedipine Drug
- Nitroglycerin transdermal Drug
- Placebo Drug
- Sildenafil Drug
- aliskiren Drug
- captopril Drug
- carbidopa Drug
- guanfacine Drug
- losartan Drug
- metoprolol tartrate Drug
- nebivolol hydrochloride Drug
- prazosin hydrochloride Drug
- tamsulosin hydrochloride Drug
Drug · Other · Dietary Supplement
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2000
- Primary completion
- Dec 31, 2016
- Completion
- Dec 31, 2016
- Last update posted
- Oct 12, 2017
2001 – 2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanderbilt University | Nashville | Tennessee | 37232 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00223717, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 12, 2017 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00223717 live on ClinicalTrials.gov.